• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UPLC-APCI-MS/MS 法测定片剂中厄贝沙坦、奥美沙坦和盐酸二甲双胍中 N-亚硝基二甲胺和 N-亚硝基二乙胺的污染

An Analytical Method for Determining N-Nitrosodimethylamine and N-Nitrosodiethylamine Contamination in Irbesartan, Olmesartan and Metformin by UPLC-APCI-MS/MS in Tablet Dosage Form.

机构信息

Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan.

Automated Chemical Laboratories, Royal Scientific Society, Amman 11941, Jordan.

出版信息

J Chromatogr Sci. 2024 Apr 23;62(4):372-379. doi: 10.1093/chromsci/bmad068.

DOI:10.1093/chromsci/bmad068
PMID:37622601
Abstract

N-nitrosamine pollutants are probable carcinogens. Regulatory agencies declared their presence in the drugs unsafe for human consumption and demanded their recall. Using ultra-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry (UPLC-APCI-MS/MS) in tablet dosage form based on International Conference on Harmonization (ICH) tripartite guideline criteria, we aim to develop and test a new approach for identifying and validating nitrosamine-contaminants, N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) in irbesartan, olmesartan and metformin. The column was Phenomenex Luna-C18, 100 × 3.0 mm and 3.0 μm. A mobile gradient phase of formic acid in either water or methanol separated the impurities. NDMA and NDEA had retention times of 0.85 and 2.55 min, respectively. The detector's linearity was established at concentrations ranging from 0.6 to 100 ng/mL. R2 for NDMA and NDEA were 0.9996 and 0.9998, respectively, with a linear response function established at 0.6-100 ng/mL. Limit of detection and limit of quantification for NDMA and NDEA were 0.35, 0.29 and 0.55, 0.37 ng/mL, respectively. On average, recovery rates for NDMA and NDEA ranged from 96.0 to 98.4 and 96.2 to 98.0%, respectively. The relative standard deviation for NDMA and NDEA was 3.46 and 2.69, respectively. According to the ICH guidelines, the developed method was quick, sensitive and valid. The pharmaceutical formulations of irbesartan, olmesartan and metformin may be regularly examined using the approach provided here.

摘要

亚硝胺污染物可能是致癌物质。监管机构宣布这些药物中存在的亚硝胺对人体食用不安全,并要求召回这些药物。本研究旨在根据国际人用药品注册技术协调会(ICH)三方指导原则标准,采用超高效液相色谱-大气压化学电离串联质谱法(UPLC-APCI-MS/MS),建立并验证一种新方法,用于检测和确证厄贝沙坦、奥美沙坦和盐酸二甲双胍中存在的亚硝胺污染物,即 N-亚硝基二甲胺(NDMA)和 N-亚硝基二乙胺(NDEA)。色谱柱为 Phenomenex Luna-C18,100×3.0mm,3.0μm。流动相为甲酸水或甲酸甲醇溶液,实现杂质分离。NDMA 和 NDEA 的保留时间分别为 0.85 和 2.55min。在 0.6-100ng/mL 浓度范围内,NDMA 和 NDEA 的检测器线性关系良好,相关系数(R2)分别为 0.9996 和 0.9998。NDMA 和 NDEA 的检测限和定量限分别为 0.35、0.29ng/mL 和 0.55、0.37ng/mL。NDMA 和 NDEA 的平均回收率范围分别为 96.0-98.4%和 96.2-98.0%。NDMA 和 NDEA 的相对标准偏差分别为 3.46%和 2.69%。根据 ICH 指南,所建立的方法快速、灵敏、有效。厄贝沙坦、奥美沙坦和盐酸二甲双胍的药物制剂可以采用本文提供的方法定期进行检测。

相似文献

1
An Analytical Method for Determining N-Nitrosodimethylamine and N-Nitrosodiethylamine Contamination in Irbesartan, Olmesartan and Metformin by UPLC-APCI-MS/MS in Tablet Dosage Form.UPLC-APCI-MS/MS 法测定片剂中厄贝沙坦、奥美沙坦和盐酸二甲双胍中 N-亚硝基二甲胺和 N-亚硝基二乙胺的污染
J Chromatogr Sci. 2024 Apr 23;62(4):372-379. doi: 10.1093/chromsci/bmad068.
2
[Determination of -nitrosodimethylamine in metformin hydrochloride and its preparations by high performance liquid chromatography-tandem mass spectrometry].高效液相色谱-串联质谱法测定盐酸二甲双胍及其制剂中的N-亚硝基二甲胺
Se Pu. 2020 Nov 8;38(11):1288-1293. doi: 10.3724/SP.J.1123.2020.03008.
3
A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.一种用于测定和定量分析阿齐沙坦、缬沙坦、替米沙坦、奥美沙坦、氯沙坦和厄贝沙坦等沙坦类药物中六种亚硝胺杂质的多分析物液相色谱-串联质谱法。
J Chromatogr Sci. 2024 Feb 2;62(2):147-167. doi: 10.1093/chromsci/bmac059.
4
Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine.在模拟胃液条件下,二甲双胍类药物会产生高浓度的亚硝酸盐依赖性 N-亚硝基二甲胺。
Sci Rep. 2024 Jun 17;14(1):13910. doi: 10.1038/s41598-024-63032-9.
5
A multianalyte LC-MS/MS method for accurate quantification of Nitrosamines in Olmesartan tablets.一种用于奥沙坦片剂中硝胺类物质准确定量的多分析物 LC-MS/MS 方法。
J Chromatogr A. 2024 Sep 13;1732:465176. doi: 10.1016/j.chroma.2024.465176. Epub 2024 Jul 18.
6
High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl-Biphenyl-Tetrazole Impurities in Losartan.高效液相色谱-串联质谱法同时测定氯沙坦中七种亚硝胺和叠氮甲基联苯四唑杂质的方法开发与验证
J Sep Sci. 2024 Oct;47(19):e202400277. doi: 10.1002/jssc.202400277.
7
The contamination of valsartan and other sartans, part 1: New findings.缬沙坦和其他沙坦类药物的污染,第 1 部分:新发现。
J Pharm Biomed Anal. 2019 Aug 5;172:395-405. doi: 10.1016/j.jpba.2019.05.022. Epub 2019 May 11.
8
Novel method for monitoring of carcinogenic impurity of N-nitrosamine in nizatidine pharmaceutical products using ultra high-pressure liquid chromatography triple quadrupole mass spectrometry.采用超高压液相色谱三重四极杆质谱法监测尼扎替丁药物制品中 N-亚硝胺致癌杂质的新方法。
Rapid Commun Mass Spectrom. 2024 Oct 15;38(19):e9884. doi: 10.1002/rcm.9884.
9
Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry.沉淀和固相萃取-气相色谱-串联质谱法测定沙坦类、二甲双胍和雷尼替丁药物中的 N-亚硝基二甲胺和 N-亚硝基甲基乙胺。
J Pharm Biomed Anal. 2020 Sep 10;189:113460. doi: 10.1016/j.jpba.2020.113460. Epub 2020 Jul 4.
10
Insight into the formation of N-nitrosodimethylamine in metformin products.深入了解二甲双胍产品中 N-亚硝基二甲胺的形成。
J Pharm Biomed Anal. 2021 Feb 20;195:113877. doi: 10.1016/j.jpba.2020.113877. Epub 2020 Dec 30.

引用本文的文献

1
Analysis and risk assessment of nitrosamines in sartans using GC-MS and Monte Carlo simulation.使用气相色谱-质谱联用仪(GC-MS)和蒙特卡洛模拟对沙坦类药物中亚硝胺进行分析和风险评估。
Sci Rep. 2025 Jun 6;15(1):20032. doi: 10.1038/s41598-025-97844-0.